The Utility of Serum Procalcitonin Level as an Early Diagnostic Biomarker for COVID in Patients Presenting with ST-Elevation Myocardial Infarction Post Primary Percutaneous Coron - Egyptian Knowledge Bank

279948

The Utility of Serum Procalcitonin Level as an Early Diagnostic Biomarker for COVID in Patients Presenting with ST-Elevation Myocardial Infarction Post Primary Percutaneous Coron

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

The Role of Procalcitonin and Serum Amyloid a As a Laboratory Biomarker in COVID-19

Article

Association between COVID-19 Diagnosis and In-Hospital Mortality of Hospitalized patients with ST-Segment Elevation Myocardial Infarction

Article

The utility of biomarkers in the discrimination of acute coronary syndrome patients

Article

Outcomes of Primary Percutaneous Coronary Intervention in Post COVID-19 Patients presenting with ST Segment Elevation Myocardial Infarction

Article

Clinical Utility of Procalcitonin in The Prediction of Cardiovascular Complications in Patients with Type 2 Diabetes Mellitus

Article

Presepsin as a predictive indicator of severity in Coronavirus disease-2019 (COVID-19)

Article

C-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection

Article

Role of measuring serum procalcitonin and receiving prophylactic antibiotic therapy in critical COVID-19 patients.

Article

The Role of Procalcitonin As an Early Biomarker in Diagnosis of Sepsis

Article

Prognostic value of Procalcitonin and Interleukin 6 in COVID-19 patients